| Current trends in the treatment of psoriasis. | |
| | |
MedLine Citation:
|
PMID: 6859798 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
New treatment modalities are now available in the management of psoriasis. We report our local studies on these new modalities. Application of dithranol for 1/2 hour is just as effective as when applied for 24 hours. This means less staining of the skin, clothes and no more burns. Oral retinoids gave more than 70% improvement in six of the seven patients with recalcitrant psoriasis. Oral retinoids produced more than 75% improvement in all eight patients with pustular psoriasis. PUVA therapy gave a complete clearance rate of 77% with an average of 25 sessions of treatment and an average total UVA dose of 346 J/cm2. However REPUVA (retinoids and PUVA) produced a complete clearance rate of 73% with an average of 18 sessions of treatment and an average total UVA dose of 142 J/cm2. The newer forms of treatment together with the established therapies have tremendously improved the total management of patients with psoriasis. |
| | |
Authors:
|
T Thirumoorthy; V S Rajan |
Related Documents
:
|
19122958 - Efficacy of 80% phenol solution in comparison with cryotherapy in the treatment of comm... 18638218 - Systemic therapy of paediatric atopic dermatitis: an update. 16766338 - Successful treatment of a therapy-resistant pyogenic granuloma with topical imiquimod 5... 2757958 - Relapse rates in moderately severe chronic psoriasis treated with cyclosporin a. 18379238 - Impact of minimal increases in serum creatinine on outcome in patients after cardiothor... 12664068 - Potency after unilateral nerve sparing surgery: a report on functional and oncological ... |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Annals of the Academy of Medicine, Singapore Volume: 12 ISSN: 0304-4602 ISO Abbreviation: Ann. Acad. Med. Singap. Publication Date: 1983 Jan |
Date Detail:
|
Created Date: 1983-07-08 Completed Date: 1983-07-08 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7503289 Medline TA: Ann Acad Med Singapore Country: SINGAPORE |
Other Details:
|
Languages: eng Pagination: 39-44 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Anthralin / therapeutic use Drug Therapy, Combination Etretinate / administration & dosage, therapeutic use* Female Humans Male Methotrexate / administration & dosage, therapeutic use Middle Aged PUVA Therapy Psoriasis / drug therapy* Time Factors Tretinoin / analogs & derivatives* |
| Chemical | |
Reg. No./Substance:
|
302-79-4/Tretinoin; 480-22-8/Anthralin; 54350-48-0/Etretinate; 59-05-2/Methotrexate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The significance of type B hyperlactataemia in infective encephalopathy.
Next Document: Dermatomyositis in a skin clinic.